NASDAQ | TSX: ACB
Largest Global Medical Cannabis Company Operating in Nationally Regulated Markets, Aurora Removes Concession Card Requirements to Access IndiMed Products in Australia
EDMONTON, AB, Feb. 14, 2025 /PRNewswire/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, in conjunction with MedReleaf Australia, recently removed the concession card requirement for patients to access medical cannabis products under the Company’s IndiMed brand. By removing this eligibility barrier, any patient in Australia can now be prescribed IndiMed products, providing greater patient access to high quality medical cannabis options.
“This change to open up patient access to MedReleaf’s IndiMed products reflects our dedication to supporting prescribers by creating more seamless and simplified prescribing options,” said Andre Jerome, Executive Vice President,…
